Biosimilars Development Drives Generic-Drug Makers’ Partnerships

Brand- and generic-drug makers continue to buddy up on biosimilars development with Baxter and Momenta Pharmaceuticals and Watson Pharmaceuticals and Amgen inking collaboration agreements.
Generic Line